Pomalidomide combined with dexamethasone for the treatment of relapsed/refractory multiple myeloma: a systematic review and meta-analysis
CONCLUSIONS: Pomalidomide combined treatment regimens have shown good clinical efficacy, especially in pomalidomide + dexamethasone combined with other drugs. In terms of safety, it's important to pay attention to the likelihood of hematological adverse events when used clinically.PMID:38421372 | DOI:10.1080/17474086.2024.2326219
Source: Expert Review of Hematology - Category: Hematology Authors: Ying Luo Chen Li Yuanchen Niu Shuanzhi Wu Jingyuan Tian Zhiqin Hu Jin He Zhixin Zhang Haiyan Liu Yongmei Li Tenghua Wang Yi Fang Source Type: research
More News: Anemia | Clinical Trials | Databases & Libraries | Dexamethasone | Hematology | Myeloma | Pneumonia | Study